Previous study indicated that the expression of the SIRT1 level was markedly lower in the tumor tissues of breast cancer, prostate cancer, bladder cancer, ovarian cancer, and glioblastoma as compared to normal tissues 39,40. Here, SIRT1 is linked to prostate carcinoma.